血脑屏障作为神经退行性疾病的治疗目标
Ruslan Rust1, Abhay P Sagare1, Mingzi Zhang1
1Department of Physiology and Neuroscience and the Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Expert opinion on drug delivery
|March 17, 2025
概括
血脑屏障 (BBB) 对大脑健康至关重要,但其破坏有助于像阿尔茨海默氏症这样的神经退行性疾病. 针对BBB恢复的治疗方法对于治疗这些疾病至关重要.
科学领域:
- 神经科学是一个神经科学.
- 血管生物学 血管生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 血脑屏障 (BBB) 是一种保护膜,可以调节大脑的进出.
- BBB功能障碍与神经退行性疾病有关,包括阿尔茨海默病 (AD).
- BBB分解可能会启动或恶化神经元和认知缺陷.
研究的目的:
- 审查BBB的分子组成及其在神经退行过程中的作用.
- 评估BBB作为神经退行性疾病的治疗点,特别是AD.
- 讨论BBB保护,恢复和药物输送的战略.
主要方法:
- 关于BBB分子组成的最新研究的文献综述.
- 针对神经退行性疾病中BBB功能治疗策略的分析.
- 检查整个BBB的药物输送方面的进展.
主要成果:
- 最近的研究揭示了BBB的复杂分子构成.
- BBB是神经退行性疾病的有前途的治疗点.
- 以BBB为导向的方法可以改善神经元功能并减缓疾病的进展.
结论:
- BBB功能障碍显著影响神经元和突触功能.
- 旨在维护或恢复BBB完整性的治疗方法对于治疗AD等神经退行性疾病至关重要.
关键词:
血脑屏障 血脑屏障 血脑屏障 血脑屏障生物学是生物学的学科.细胞治疗疗法细胞治疗疗法药物输送是药物输送的过程.基因治疗的基因疗法神经退行性疾病是一种神经退行性疾病.小分子的小分子.治疗目标是治疗的目标.更多相关视频
08:43Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
Published on: November 30, 2012
19.4K
07:22Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
Published on: November 8, 2017
9.9K
相关概念视频
00:49The Blood-brain Barrier
46.5K
Overview
46.5K
01:23Factors Affecting Drug Distribution: Physiological Barriers
154
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
154
01:22Alzheimer's Disease: Treatment
139
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
139